Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | UNK | — | — |
Pt was diagnosed with POTS about 3-4 years ago. She attributes it to the GARDASIL vaccine.; This spontaneous report was received from a Consumer or other non-health professional and refers to a female patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication. On an unknown date, the patient started therapy with Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) for prophylaxis (dose, route of administration, anatomical location, lot number and expiration date were not reported). On an unspecified date in 2021 (reported as "about 3-4 years ago"), the patient was diagnosed with Postural orthostatic tachycardia syndrome (POTS). The outcome of the event was unknown. The reporter attributed the Postural orthostatic tachycardia syndrome to the Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) vaccine, based on the book in her post and information they heard from other people before the book came out. The reporter did not know if a direct causal relationship between POTS and Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) was actually established by her doctor. Lot # is being requested and will be submitted if received.